TUMOR MICROENVIRONMENT CHIP (TME-CHIP)
PYTHIA BIOTECH LTD.
TUMOR MICROENVIRONMENT CHIP (TME-CHIP)
PYTHIA BIOTECH LTD.
Back to Hall of Fame
Pythia Biotech Ltd. has developed an advanced Tumor Microenvironment Chip (TME-Chip) platform that provides a human-relevant tumor model, enabling researchers to evaluate drug efficacy, predict patient responses, identify novel therapeutic strategies, and investigate complex biological processes such as drug resistance and metastasis. By bridging the gap between preclinical studies and clinical outcomes, this platform has the potential to accelerate personalized therapy development and enhance the success rate of clinical trials.
Highlights
- The U-Shaped 3D Culture Chamber with Microfluidic Circulation enables high-resolution imaging and dynamic drug delivery, closely mimicking physiological perfusion.
- Features established customizable hydrogel-based mono- and co-culture systems comprising tumor, immune, and stromal cells.
- Supports real-time live-cell imaging for dynamic observation of cellular responses.
- Accurate recapitulation of tumor architecture and TME gradients reflects oxygen, cytokine, and drug diffusion patterns, bridging the gap between conventional 2D cultures and in vivo systems.
- Predictive, reproducible, and scalable platform supports high-content imaging, enables quantitative analysis, and accelerates oncology drug development and precision medicine research.
View Website
Back to Hall of Fame
Pythia Biotech Ltd. has developed an advanced Tumor Microenvironment Chip (TME-Chip) platform that provides a human-relevant tumor model, enabling researchers to evaluate drug efficacy, predict patient responses, identify novel therapeutic strategies, and investigate complex biological processes such as drug resistance and metastasis. By bridging the gap between preclinical studies and clinical outcomes, this platform has the potential to accelerate personalized therapy development and enhance the success rate of clinical trials.
Highlights
- The U-Shaped 3D Culture Chamber with Microfluidic Circulation enables high-resolution imaging and dynamic drug delivery, closely mimicking physiological perfusion.
- Features established customizable hydrogel-based mono- and co-culture systems comprising tumor, immune, and stromal cells.
- Supports real-time live-cell imaging for dynamic observation of cellular responses.
- Accurate recapitulation of tumor architecture and TME gradients reflects oxygen, cytokine, and drug diffusion patterns, bridging the gap between conventional 2D cultures and in vivo systems.
- Predictive, reproducible, and scalable platform supports high-content imaging, enables quantitative analysis, and accelerates oncology drug development and precision medicine research.